Ubs Group Ag Simulations Plus, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 14,710 shares of SLP stock, worth $467,336. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,710

Previous 10,175 44.57%

Holding current value

$467,336

Previous $494,000 4.86%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$30.46 - $46.86 $138,136 - $212,510	4,535 Added 44.57%	14,710 $470,000
Q2 2024 Aug 13, 2024	SELL	$38.46 - $50.95 $256,028 - $339,174	-6,657 Reduced 39.55%	10,175 $494,000
Q1 2024 May 13, 2024	SELL	$37.48 - $44.74 $182,827 - $218,241	-4,878 Reduced 22.47%	16,832 $692,000
Q4 2023 Feb 09, 2024	BUY	$33.36 - $45.71 $317,320 - $434,793	9,512 Added 77.98%	21,710 $971,000
Q3 2023 Nov 09, 2023	SELL	$40.03 - $51.51 $363,192 - $467,350	-9,073 Reduced 42.65%	12,198 $508,000
Q2 2023 Aug 11, 2023	BUY	$40.45 - $48.0 $188,416 - $223,584	4,658 Added 28.04%	21,271 $921,000
Q1 2023 May 12, 2023	BUY	$34.96 - $43.94 $48,594 - $61,076	1,390 Added 9.13%	16,613 $729,000
Q4 2022 Feb 08, 2023	BUY	$36.55 - $51.15 $174,599 - $244,343	4,777 Added 45.73%	15,223 $556,000
Q3 2022 Nov 10, 2022	SELL	$47.75 - $66.88 $47,941 - $67,147	-1,004 Reduced 8.77%	10,446 $507,000
Q2 2022 Aug 10, 2022	SELL	$40.55 - $51.76 $190,625 - $243,323	-4,701 Reduced 29.11%	11,450 $565,000
Q1 2022 May 16, 2022	SELL	$36.56 - $50.98 $111,069 - $154,877	-3,038 Reduced 15.83%	16,151 $823,000
Q4 2021 Feb 14, 2022	SELL	$37.1 - $57.45 $32,796 - $50,785	-884 Reduced 4.4%	19,189 $908,000
Q3 2021 Nov 15, 2021	BUY	$38.45 - $55.66 $71,786 - $103,917	1,867 Added 10.25%	20,073 $793,000
Q2 2021 Aug 13, 2021	SELL	$49.67 - $68.96 $332,391 - $461,480	-6,692 Reduced 26.88%	18,206 $999,000
Q1 2021 May 12, 2021	SELL	$60.06 - $89.52 $1.31 Million - $1.95 Million	-21,805 Reduced 46.69%	24,898 $1.57 Million
Q4 2020 Feb 11, 2021	BUY	$53.26 - $77.18 $1.39 Million - $2.02 Million	26,139 Added 127.11%	46,703 $3.36 Million
Q3 2020 Nov 12, 2020	SELL	$57.51 - $75.36 $112,719 - $147,705	-1,960 Reduced 8.7%	20,564 $1.55 Million
Q2 2020 Jul 31, 2020	SELL	$32.91 - $59.82 $8,326 - $15,134	-253 Reduced 1.11%	22,524 $1.35 Million
Q1 2020 May 01, 2020	SELL	$26.79 - $38.99 $266,506 - $387,872	-9,948 Reduced 30.4%	22,777 $796,000
Q4 2019 Feb 14, 2020	BUY	$29.07 - $35.63 $212,094 - $259,956	7,296 Added 28.69%	32,725 $952,000
Q3 2019 Nov 14, 2019	BUY	$28.19 - $41.75 $194,821 - $288,534	6,911 Added 37.32%	25,429 $883,000
Q2 2019 Aug 14, 2019	BUY	$19.91 - $28.97 $104,885 - $152,613	5,268 Added 39.76%	18,518 $529,000
Q1 2019 May 14, 2019	SELL	$18.84 - $21.36 $226,946 - $257,302	-12,046 Reduced 47.62%	13,250 $280,000
Q4 2018 Feb 14, 2019	BUY	$17.56 - $21.2 $18,332 - $22,132	1,044 Added 4.3%	25,296 $504,000
Q3 2018 Nov 14, 2018	BUY	$17.1 - $23.55 $28,386 - $39,093	1,660 Added 7.35%	24,252 $490,000
Q2 2018 Aug 14, 2018	SELL	$14.65 - $23.75 $66,511 - $107,825	-4,540 Reduced 16.73%	22,592 $502,000
Q1 2018 May 15, 2018	BUY	$14.4 - $16.8 $331,632 - $386,904	23,030 Added 561.43%	27,132 $400,000
Q4 2017 Feb 14, 2018	BUY	$15.3 - $17.4 $29,314 - $33,338	1,916 Added 87.65%	4,102 $66,000
Q3 2017 Nov 14, 2017	BUY	$13.7 - $15.65 $3,534 - $4,037	258 Added 13.38%	2,186 $34,000
Q2 2017 Aug 14, 2017	SELL	N/A	-1,734 Reduced 47.35%	1,928 $24,000
Q1 2017 Nov 14, 2017	BUY	N/A	3,662	3,662 $43,000

Others Institutions Holding SLP

# of Institutions

176

Shares Held

15.2M

Call Options Held

5.4K

Put Options Held

1.4K

View Full List

About Simulations Plus, Inc.

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $645M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

More about SLP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account